Stock search

Ticker or company name

Intuitive Surgical

ISRG · NASDAQ · Health Care

$437,75Down −5,84 (−1,32%)today

Quotes delayed up to 15 min. Updated 16 Nov, 16:00 New York time

Market cap
$152 bn
Div. yield
—
Year to date
−21,7%
52 weeks: $328,57$603,88

Ratio score

83/100
Ratio would consider buying

based on 9 metrics as of 16.11.2026 ·

Verdict by our methodology based on current metrics. Not an investment recommendation.

Key metrics

7 ✓ · 1 — · 1 ✕ · 1 n/a · hover over a row or tap it to see the trend

All metrics

MetricValue5-year medianIndustry median
P/E TTM52,069,325,1
Forward P/E35,3—16,2
PEG3,1—2,2
P/S13,317,32,2
EV/EBITDA42,362,317,3
P/FCF42,7—19,5
P/B9,59,43,4

Industry median — across 33 profitable companies in “Health Care” in Ratio. Revenue and EPS forecasts for future years and the number of employees are in the paid data plan.

Price chart

Compare with

Choose a stock

Closing prices adjusted for splits and dividends. The S&P 500 index and the intraday chart come later.

Analysts

Ratings, 40 analysts

Buy
30
Hold
9
Sell
1

Beat the EPS forecast in 4 of the last 4 quarters

QuarterEstimateActualSurprise
Q3 20262,703,00Up +11,3%
Q2 20262,552,80Up +9,8%
Q1 20262,142,50Up +16,8%
Q4 20252,302,53Up +9,9%

Price targets and yearly revenue and EPS forecasts are in the paid data plan. These are analysts' opinions, not our verdict.

Financials in charts

MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23
Revenue3,05 bn2,89 bn2,77 bn2,87 bn2,51 bn2,44 bn2,25 bn2,41 bn2,04 bn2,01 bn1,89 bn1,93 bn
EPS1,492,292,282,201,951,811,921,891,561,461,511,69
Margin17,1%28,3%29,6%27,7%28,1%27,0%31,0%28,4%27,7%26,2%28,8%31,4%
FCF1,11 bn948 m809 m730 m736 m560 m465 m511 m459 m311 m23,5 m−207 m

From SEC reports. TTM is the sum of 4 quarters; a year is TTM at the end of the calendar year. Forecast bars are in the paid data plan.

Owners

Ownership structure and major holders (13F filings) are in the paid data plan. They are not part of the score or the traffic light.

Insider trades over 12 months

Over 12 months: no purchases, sales $65,4 m.

NameAmountSharesPrice
loeb gary10 Nov 2026 · sale$183 260400$458,15
guthart gary s4 Nov 2026 · sale$4,57 m10 000$457,34
barratt craig h4 Nov 2026 · sale$529 0031 150$460,00
brosius mark30 Oct 2026 · sale$28 57763$453,60
widman fredrik30 Oct 2026 · sale$2,38 m5 448$436,06
brosius mark29 Oct 2026 · sale$27 31961$447,85
brosius mark28 Oct 2026 · sale$26 93861$441,60
brosius mark27 Oct 2026 · sale$27 54961$451,63
brosius mark26 Oct 2026 · sale$27 55761$451,75
widman fredrik23 Oct 2026 · sale$1,83 m4 047$453,21
guthart gary s23 Oct 2026 · sale$9,08 m20 095$451,61
barratt craig h23 Oct 2026 · sale$510 3701 150$443,80
wadors patricia l23 Oct 2026 · sale$478 4161 078$443,80
widman fredrik15 Sep 2026 · sale$203 321543$374,44
widman fredrik15 Sep 2026 · sale$204 444546$374,44

SEC Form 4. Titles and trading plans are not in the data. They are not part of the score or the traffic light.

About the company

Industry
Health Care
Exchange
NASDAQ
Country
US
IPO date
13 Jun 2000

Company description, revenue by segment and region, and the CEO will come later.

Next report
date not announced

An AI summary of the earnings call will come later.

Peers

CompanyPrice
MDTMedtronic$102,8878would consider25,1+9,8%13,9%
MCKMcKesson$1 105,0472would consider27,3+8,2%1,1%
ABTAbbott Laboratories$107,4533would not consider40,0+10,0%9,7%
SYKStryker Corporation$310,7272would consider33,0+7,9%13,8%
CVSCVS Health$88,5983would consider10,4+6,7%2,6%
Compare with peers

Ratio — a score by our methodology, not an investment recommendation.